Liver histology according to the presence of metabolic syndrome in nonalcoholic fatty liver disease cases
dc.contributor.author | Bıyıklı, Zeynep | |
dc.contributor.buuauthor | Uslusoy, Hüseyin Saadettin | |
dc.contributor.buuauthor | Nak, Selim Giray | |
dc.contributor.buuauthor | Gülten, Macit | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Gastroenteroloji Anabilim Dalı. | tr_TR |
dc.contributor.scopusid | 8886940400 | tr_TR |
dc.contributor.scopusid | 6603336505 | tr_TR |
dc.contributor.scopusid | 6603629209 | tr_TR |
dc.date.accessioned | 2022-01-25T11:12:25Z | |
dc.date.available | 2022-01-25T11:12:25Z | |
dc.date.issued | 2009-03-07 | |
dc.description.abstract | AIM: To investigate the histologic features of the liver in nonalcoholic fatty liver disease (NAFLD) cases according to the presence of metabolic syndrome or its individual components. METHODS: We enrolled 81 patients (40 male, 41 female) who were diagnosed with fatty liver by ultrasonographic scan and fulfilled the inclusion criteria. First anamnesis, anthropometric, clinical, laboratory and imaging features of all participants were recorded and then liver biopsy was performed after gaining consent from patients. Diagnosis of metabolic syndrome was dependent on patients having 3 or more out of 5 risk criteria defined by the WHO. Biopsy specimens were assessed according to Brunt et al's classification. RESULTS: Sixty-nine of the 81 patients had nonalcoholic steatohepatitis (NASH), 11 had simple fatty liver and 1 had cirrhosis according to histologic evaluation. Comparisons were made between two groups of NASH patients, those with and without metabolic syndrome. We did not detect statistically significant differences in liver histology between NASH patients with and without metabolic syndrome. CONCLUSION: NASH can progress without metabolic risk factors or the presence of metabolic syndrome. | en_US |
dc.identifier.citation | Uslusoy, H. S. vd. (2009). "Liver histology according to the presence of metabolic syndrome in nonalcoholic fatty liver disease cases". World Journal of Gastroenterology, 15(9), 1093-1098. | en_US |
dc.identifier.endpage | 1098 | tr_TR |
dc.identifier.issn | 1007-9327 | |
dc.identifier.issue | 9 | tr_TR |
dc.identifier.pubmed | 19266602 | tr_TR |
dc.identifier.scopus | 2-s2.0-65549088089 | tr_TR |
dc.identifier.startpage | 1093 | tr_TR |
dc.identifier.uri | https://doi.org/10.3748/wjg.15.1093 | |
dc.identifier.uri | https://www.wjgnet.com/1007-9327/full/v15/i9/1093.htm | |
dc.identifier.uri | http://hdl.handle.net/11452/24286 | |
dc.identifier.volume | 15 | tr_TR |
dc.identifier.wos | 000264152300010 | tr_TR |
dc.indexed.pubmed | Pubmed | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Baishideng Publishing Group | en_US |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.relation.journal | World Journal of Gastroenterology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Liver histology | en_US |
dc.subject | Metabolic risk factors | en_US |
dc.subject | Metabolic syndrome | en_US |
dc.subject | Nonalcoholic steatohepatitis | en_US |
dc.subject | Patty liver | en_US |
dc.subject | Insulin-resistance | en_US |
dc.subject | Steatohepatitis | en_US |
dc.subject | Fibrosis | en_US |
dc.subject | Complications | en_US |
dc.subject | Association | en_US |
dc.subject | Definition | en_US |
dc.subject | Predictors | en_US |
dc.subject | Severity | en_US |
dc.subject | Spectrum | en_US |
dc.subject | Nash | en_US |
dc.subject | Gastroenterology & hepatology | en_US |
dc.subject.emtree | Alanine aminotransferase | en_US |
dc.subject.emtree | Alkaline phosphatase | en_US |
dc.subject.emtree | Aspartate aminotransferase | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Anamnesis | en_US |
dc.subject.emtree | Anthropometry | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Clinical examination | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Echography | en_US |
dc.subject.emtree | Fatty liver | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Histopathology | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Human tissue | en_US |
dc.subject.emtree | Image analysis | en_US |
dc.subject.emtree | Informed consent | en_US |
dc.subject.emtree | Laboratory test | en_US |
dc.subject.emtree | Liver biopsy | en_US |
dc.subject.emtree | Liver cirrhosis | en_US |
dc.subject.emtree | Major clinical study | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Medical record | en_US |
dc.subject.emtree | Metabolic syndrome X | en_US |
dc.subject.emtree | Nonalcoholic fatty liver | en_US |
dc.subject.emtree | Risk assessment | en_US |
dc.subject.emtree | Sex difference | en_US |
dc.subject.emtree | Biopsy | en_US |
dc.subject.emtree | Blood | en_US |
dc.subject.emtree | Body mass | en_US |
dc.subject.emtree | Diabetes mellitus | en_US |
dc.subject.emtree | Disease course | en_US |
dc.subject.emtree | Fatty liver | en_US |
dc.subject.emtree | Glucose tolerance test | en_US |
dc.subject.emtree | Liver | en_US |
dc.subject.emtree | Liver cirrhosis | tren_US |
dc.subject.emtree | Obesity | en_US |
dc.subject.emtree | Pathology | en_US |
dc.subject.emtree | Risk factor | en_US |
dc.subject.emtree | Waist hip ratio | en_US |
dc.subject.mesh | Alanine transaminase | en_US |
dc.subject.mesh | Alkaline phosphatase | en_US |
dc.subject.mesh | Aspartate aminotransferases | en_US |
dc.subject.mesh | Biopsy | en_US |
dc.subject.mesh | Body mass index | en_US |
dc.subject.mesh | Diabetes complications | en_US |
dc.subject.mesh | Diabetes mellitus | en_US |
dc.subject.mesh | Disease progression | en_US |
dc.subject.mesh | Fatty liver | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Glucose tolerance test | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Liver | en_US |
dc.subject.mesh | Liver cirrhosis | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Metabolic syndrome X | en_US |
dc.subject.mesh | Obesity | en_US |
dc.subject.mesh | Risk factors | en_US |
dc.subject.mesh | Waist-hip ratio | en_US |
dc.subject.scopus | Fatty Liver; Proton Density (Concentration); Keratin-18 | en_US |
dc.subject.wos | Gastroenterology & hepatology | en_US |
dc.title | Liver histology according to the presence of metabolic syndrome in nonalcoholic fatty liver disease cases | en_US |
dc.type | Article | |
dc.wos.quartile | Q3 | en_US |